Product Images Gabapentin

This is a description of a medication called Gabapentin available as 600 mg tablets in a bottle of 30. It has a lot number, pill identification number, and an expiry date of December 31, 2020. It is manufactured by Acihealthcare and has a SIN and batch number. Dosage instructions can be found in the package insert and it is to be stored at a controlled room temperature between 20-25°C (68-77°F) with permitted excursions to 15-30°C (50-86°F). The medication is packaged by Cantract Pharmacy Servines-PA and has an NDC of 67046-341-30.*

Gabapentin is a prescription-only medication available in tablet form. Each tablet contains 800mg of Gabapentin, and each package contains 30 tablets. The expiration date of the medication is 12/31/2020. This medication is manufactured in accordance with USP standards. The usual dose is only available through the full prescribing information. The tablets can be stored at a temperature of 20-25°C (68-77°F), but excursions to 15-30°C (59-86°F) are permitted. The packaging was done by Contract Pharmacy Services-PA. The National Drug Code (NDC) for the 30-tablet package is 67046-413-30. The Lot and Batch numbers have been masked for privacy.*

This text describes a formula for calculating the estimated creatinine clearance (CLOr) of a patient. It involves multiplying the patient's age (in years) by their weight (in kg) and dividing by a constant value of 72 multiplied by their serum creatinine level (in mg/dL). For female patients, an additional step of multiplying by 0.85 is required.*

This text is providing the results of a study evaluating pain scores over a 4-week fixed dose period for two different treatments, Gabapentin at 1800 mg/day and Gabapentin at 2400 mg/day, compared to a placebo. The data includes mean pain scores at baseline and throughout the 7-day evaluation period.*

This is a chart showing the proportion of responders who experienced more than 50% reduction in pain score in controlled PHN studies. There are two studies presented and both have a significant p-value of less than 0.001. The data presents the percentage of responders for each study, one of which had 32% responders while the other had 34%. The chart also includes information on the cost of treatment with GBP 3600, GBP 1800, and GBP 2400.*